New contract reinforces Kincell Bio’s commitment to long-term partnerships to address development and GMP manufacturing support for engineered cellular therapies. Gainesville, Florida (September 16, 2024)...
New contract reinforces Kincell Bio’s commitment to long-term partnerships to address development and GMP manufacturing support for engineered cellular therapies. Gainesville, Florida (September 16, 2024)
Read moreNew contract reinforces Kincell Bio’s commitment to long-term partnerships to address development and GMP manufacturing support for engineered cellular therapies. Durham, North Carolina (September 4,
Read moreKincell Bio’s Jessica Carmen outlines how savvy cell therapy innovators can avoid expensive corner-cutting with strategic spending choices.
We conducted a study assessing the
effect of three commercially available cGMP grade medias and their influence on T-cell phenotype.
Serial entrepreneur has created, built and sold three CDMOs GAINESVILLE, Fla. – May 21, 2024 – Kincell Bio, LLC (“Kincell”), a technology-forward contract development and
Read moreKincell Bio is attending CASSS Cell & Gene Therapy Products! To connect with Bruce while we’re there, please let us know you’re coming here.
